Scynexis CEO talks recent ibrexafungerp approval

Video

Marco Taglietti, MD, president and CEO of Scynexis, sits with Contemporary OB/GYN® to discuss the recent approval of ibrexafungerp (Brexafemme) for the reduction in incidence of recurrent vulvovaginal candidiasis.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!
Recent Videos
Ryan Haumschild, PharmD
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Related Content
FDA accepts priority review for gepotidacin as oral treatment for gonorrhea | Image credit Contemporary OB/GYN

FDA accepts gepotidacin for priority review for gonorrhea oral treatment

Morgan Ebert, Managing Editor
September 16th 2025
Article

Read More

S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

Lindsey Carr, Editor;Jessica Y. Shim, MD
September 16th 2025
Podcast

Listen

FDA extends review period for Bayer's elinzanetant for vasomotor symptoms | Image credit: Contemporary OB/GYN

FDA extends review period for Bayer's elinzanetant for vasomotor symptoms

Morgan Ebert, Managing Editor
September 16th 2025
Article

Read More

S4E1: New RNA platform can predict pregnancy complications

S4E1: New RNA platform can predict pregnancy complications

September 16th 2025
Podcast

Listen

Experts urge FDA to revise boxed warnings on hormone therapies for menopause | Image credit: Contemporary OB/GYN

Experts urge FDA to revise boxed warnings on hormone therapies for menopause

Morgan Ebert, Managing Editor
September 16th 2025
Article

Read More

DM199 shows promise in phase 2 trial for treating preeclampsia | Image Credit: © Egor - © Egor - stock.adobe.com.

DM199 shows promise in phase 2 trial for treating preeclampsia

Celeste Krewson, Assistant Editor
September 16th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.